2 completed, 1 terminated. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow laninamivir: new trials by email Literature Review of laninamivir trials Research Report on laninamivir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety & Pharmacokinetics Study of Inhaled Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Children With Influenza 20 mg laninamivir octanoate, Placebo, 40 mg laninamivir octanoate - Influenza | Phase 1 / Phase 2 | Terminated | Biota Scientific Management Pty Ltd | 15 | 2013-11-01 | 2025-01-13 |
| Safety, Tolerability and Pharmacokinetics of Inhaled Laninamivir Octanoate TwinCaps® DPI in Adults With Chronic Asthma Laninamivir octanoate - Asthma | Phase 1 | Completed | Biota Scientific Management Pty Ltd | 32 | 2013-10-01 | 2018-05-30 |
| Safety, Tolerability and Pharmacokinetic Study of Multiple Doses of CS-8958 CS-8958, Placebo - Influenza | Phase 1 | Completed | Biota Scientific Management Pty Ltd | 16 | 2009-04-01 | 2018-05-30 |
Influenza, Human (2) · Asthma (1) · Lymphoma, Follicular (1)
Biota Scientific Management Pty Ltd (3)
United Kingdom (2) · United States (1)
Jolanta Airey, Dr (2) · Jane Ryan, PhD (1)
1UC1AI062373-01 (1), 2008 (1)